Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of course of therapy on response rate and duration with the Bexxar® therapeutic regimen (tositumomab and iodine I 131 tositumomab) and with chemotherapy
    Meeting Abstract

    Leonard, J. P.; Zelenetz, A. D.; Vose, J. M.; Kaminski, M. S.
    Blood (2004)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) of fixed dose rate gemcitabine in patients with liver metastases from colorectal carcinoma. A phase I study with pharmocokinetic analysis
    Meeting Abstract

    Leonard, G. D.; Sperber, D. ; O'connor, O.; Kemeny, N. E.
    Annals of Oncology (2004)

    Fulltext@MSK | Save
  • Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases
    Meeting Abstract

    Leonard, G. D.; Fong, Y.; Jarnagin, W.; Harris, R.; Schwartz, L.; D'Angelica, M.; Paty, P.; DeMatteo, R.; Blumgart, L.; Kemeny, N.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide with or without rituximab has significant activity in patients with previously treated chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J.; Scheinberg, D. A.; Gencarelli, A. N.; Horgan, D.; Weiss, M. A.
    Blood (2004)

    Fulltext@MSK | Save
  • MEF regulates hematopoietic stem cell quiescence and hematologic recovery post-myelosuppression
    Meeting Abstract

    Lacorazza, H. D.; Nunes, J.; Nimer, S. D.
    Experimental Hematology (2004)

    Fulltext@MSK | Save
  • Primary peritoneal mesothelioma: How aggressive should we be?
    Meeting Abstract

    Labow, D. M.; Coit, D. G.; Kelsen, D.; Shia, J.; Freeman, S.; Weiser, M. R.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial
    Meeting Abstract

    Krug, L. M.; Crapanzano, J. P.; Miller, V. A.; Azzoli, C. G.; Rizvi, N.; Gomez, J.; Pizzo, B.; Tyson, L.; Dunne, M.; Kris, M. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase II study of temozolomide (TMZ) and pegylated interferon alpha-2b (PGI) in the treatment of advanced melanoma
    Meeting Abstract

    Krown, S. E.; Hwu, W. J.; Menell, J. H.; Panageas, K. S.; Lamb, L. A.; Aird, S.; Williams, L. J.; Chapman, P. B.; Livingston, P. O.; Wolchok, J. D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC)
    Meeting Abstract

    Kris, M. G.; Sandler, A.; Miller, V.; Cespon, M.; Zakowski, M.; Pizzo, B.; Venkatraman, E.; Gomez, J.; Johnson, D.; Carbone, D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Inhibitors of the epidermal growth factor receptor tyrosine kinase: targeted therapy hits the Bullseye in patients with non-small-cell lung cancer
    Meeting Abstract

    Kris, M. G.
    Lung Cancer (2004)

    Fulltext@MSK | Save